#TalkClinicalTrials: Calling all allies!
In this #TalkClinicalTrials blog, Kim Meeking, Co-lead Queering Cancer explores why 2SLGBTQ+ inclusion in clinical trials must go beyond intention—embedding allyship into every step of the research process. From addressing bias to redesigning eligibility criteria, Kim outlines how clinical trials can become more inclusive, accessible, and affirming for everyone. Everyone can be an ally. Whether […]